Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
about
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes PathogenesisBeta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targetsRecent advances in understanding Type 1 DiabetesT cell epitopes and post-translationally modified epitopes in type 1 diabetesImmune recognition of citrullinated epitopes.Prelude to oral microbes and chronic diseases: past, present and futureProtein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.Detection and identification of protein citrullination in complex biological systemsAnalysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes.Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'.The beta-cell in type 1 diabetes: What have we learned from proteomic studies?Combination immunotherapies for type 1 diabetes mellitus.New Insights and Biomarkers for Type 1 Diabetes: Review for Scandinavian Journal of Immunology.β cell ER stress and the implications for immunogenicity in type 1 diabetes.Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetesEndoplasmic reticulum stress in beta cells and autoimmune diabetes.Early differences in islets from prediabetic NOD mice: combined microarray and proteomic analysis.Understanding type 1 diabetes through proteomics.Antibodies to post-translationally modified insulin in type 1 diabetes.Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase.Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes.NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count.Oxidative Modifications in Tissue Pathology and Autoimmune Disease.Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase.Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse.The progress and potential of proteomic biomarkers for type 1 diabetes in children.An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse.Current Strategies to Enhance Anti-Tumour Immunity.Modifying Enzymes are Elicited by ER Stress, Generating Epitopes that are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes.A proteomic study of the regulatory role for STAT-1 in cytokine-induced beta-cell death.IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.Determining T-cell specificity to understand and treat diseaseIslet stress, degradation and autoimmunity
P2860
Q26750714-08A82236-DD83-4505-B8AA-06EB6E11C849Q26751244-6190453B-596C-4772-84DF-8864E8BE2549Q26766139-85752348-FE4B-4436-82E2-0AC85EB78CD7Q26787014-DFD281B5-8CB8-480E-96C7-EF004DA9AA7BQ30391892-33641EAA-26ED-4319-B20F-1EB86F6494F9Q34468829-94B185A3-8D6D-43D0-8E2A-0E44AB092171Q36098256-0381A403-6E00-417D-84A6-9FFD474DCF44Q36301061-451D72BC-891C-4378-BDEA-385F7F83C594Q36515404-AE48B76F-B0D6-4EAC-919E-99A4EA4C6CCEQ37478584-07E4F15F-7EA2-4EB5-ADA8-B12F29051B64Q37698306-1F1013C4-C88F-492F-B522-9FBA5587FDC1Q38340362-0B911591-26A0-4A6B-827D-24E7C24FEB08Q38358009-FFFC3B1B-060C-4E49-89BA-1566D9E4927BQ38539481-704F9319-A102-401B-8379-B3FFD65B7F19Q38637035-C099ECC5-6B04-45A5-A7FD-B9173BEDE252Q38771484-875AC9A7-C964-420F-A5E9-2097031F9023Q38975660-3DDA951A-8925-46D5-931E-06D0D8A1B929Q39025801-A52A4AA8-522F-4BD1-94E5-F16828C691F9Q39398068-208E5A5F-AD27-47C0-893F-DE2164C482D0Q40561404-3AE391E7-602F-499A-A429-313845E96D6CQ40998700-E5B35999-7A33-4D1D-BA1E-EB232ECC9B1BQ41092744-BECF84FD-55A3-4E52-96CD-5E4D9A264135Q42369799-F12F7A0D-D180-41CD-8208-C5DB743A3A6DQ45028780-094449A7-E7F4-402D-9B24-5FE991DD66A6Q45989245-52C20990-05FF-4F01-9FF2-336D787E710DQ46303593-99522F37-5436-4F2E-8115-5DB299FA5A23Q47614555-0446F6C1-037B-4DC5-BFDF-5FB4E64C5407Q48003839-11B08D53-4610-4ED9-B5C9-367812A8F767Q48720838-9ABA8313-73FA-40A9-99DA-8BE151FE4E69Q51350685-0C728063-3533-45CD-BE51-915ED098BA14Q52344613-4D15459D-DBD6-48FC-9DB5-504496FAFDADQ52719485-0B2ADB28-8B61-427E-81C1-F5674315AFD6Q53604777-46ABABF5-0140-4E28-A75F-A089A3B5B0DBQ55283549-985BC42C-B1D4-4DE8-AD53-77B9DCCBB648Q57201489-4A6E37F4-A77D-4ACE-AED6-DFEB0A001F21Q58715113-92147E55-5BF0-4D02-A0DF-F576C3B568EB
P2860
Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
@en
Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
@nl
type
label
Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
@en
Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
@nl
prefLabel
Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
@en
Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
@nl
P2093
P50
P356
P1433
P1476
Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
@en
P2093
Decio L Eizirik
Dieter Rondas
Gabriela Bomfim Ferreira
Inne Crèvecoeur
Kris Gevaert
Lut Overbergh
Wannes D'Hertog
P304
P356
10.2337/DB14-0621
P407
P577
2014-09-09T00:00:00Z